Abarelix | CAS:183552-38-7

We serve Abarelix CAS:183552-38-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Abarelix

Chemical Name:Abarelix
CAS.NO:183552-38-7
Synonyms:Abarelix
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 1688.4±65.0 °C at 760 mmHg
Molecular Formula C72H95ClN14O14
Molecular Weight 1416.063
Flash Point 974.9±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.601
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Abarelix is a synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). It directly and competitively binds and blocks the gonadotropin releasing hormone receptors in the anterior pituitary, which inhibits the secretion and release of the luteinizing hormone (LH) and follicle stimulating hormone (FSH). For men, the inhibition of LH secretion prevents the release of testosterone. Therefore, it can relieve symptoms associated with prostate hypertrophy or prostate cancer.



Contact us for information like Abarelix chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Abarelix physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Abarelix Use and application,Abarelix technical grade,usp/ep/jp grade.


Related News: DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.2,4,6-TRICHLOROPHENYL ISOTHIOCYANATE manufacturer Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days.(2S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile supplier The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.trans,trans-2,4-Heptadienal vendor Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.